drugset / Trial / NCT04606329
To Evaluate the Efficacy and Safety of LuminoMark Injection in Patients With Nonpalpable Breast Lesions(Phase 3)
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is a multicenter, Randomized, Open-label, Parallel, Phase 3 Clinical Trial in 8 weeks for screening, once Investigational product injection, Follow up visit.
Timeline
- Start
- 2020-07-20
- Primary completion
- 2021-01-28
- Completion
- 2021-01-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Charcotrace | Unknown | 0.3 ml | — |
| Comparator | Charcotrace | Unknown | 1 ml | — |
| Subject | LuminoMark | Diagnostic / imaging agent | 0.2 ml | — |